注册人更新档案以及更广泛地了解早期阶段的通用筛选方法有什么好处？在沟通/规划中是否应该考虑这一点？

注册人更新档案以及更广泛地了解早期阶段的通用筛选方法有什么好处？在沟通/规划中是否应该考虑这一点？

What are the benefits for the registrant to update the dossier and more generally to learn about the early phases of the common screening approach? Should this be considered in the communication/planning

在共同筛选的早期阶段，开展信函活动和与注册人互动的目的之一是提高主管部门在物质选择早期阶段工作的透明度，并使注册人能够阐明其物质的潜在危害和用途。注册档案质量的提高反过来会为主管部门提供更坚实的基础，以决定是否需要采取进一步行动。因此，如果我们在注册档案中拥有关于危害和用途的正确信息，这将影响物质被选择用于进一步流程的方式。这意味着，例如，如果一种物质主要在严格的控制下处理，主管部门就不想花时间对其进行筛选。事实上，从监管风险管理的角度来看，我们关注重要且用途相关的物质符合主管部门和行业的利益。

One of the aims of the letter campaign and interaction with Registrants in the early phases of common screening is to increase transparency of authorities' work in the early stages of substance selection and to give Registrants the possibility to clarify the potential hazard and use profile of their substances. The improved quality of the registration dossiers will in turn provide authorities a more solid basis for deciding on the need for further actions. Therefore, if we have in registration dossiers the right information on hazard and uses this will impact the way substances are selected for further processes. Which means, for example, that if a substance is mainly handled under rigorous containment the authorities do not want to spend time on screening it. It is in fact in the interest of both authorities and industry that we focus on substances that matter and for which uses are of relevance from a regulatory risk management perspective.